The global automated visual field analyzer market size was valued at USD 208.66 million in 2024 and is anticipated to grow from USD 221.43 million in 2025 to reach USD 356.13 million in 2033, growing at a CAGR of 6.12% during the forecast period (2025–2033).
Visual field analyzers are frequently utilized in detecting and diagnosing abnormalities in the brain in addition to conditions such as glaucoma, AMD, and scotomas. These analyzers examine the patient's vision, both horizontally and vertically, to locate any probable blind or decreased patches (scotomas) in the patient's field of peripheral vision. Detecting particular scotomas in a person's field of vision may suggest a particular kind of brain injury or diseases, such as a stroke or a tumor. The patient is given instructions to identify particular light stimuli shown by the analyzer in the patient's periphery; if the patient is unable to recognize the stimuli, this may suggest that the patient has suffered from trauma and/or scotomas.
Loss of peripheral vision and other visual field abnormalities can be caused by a wide variety of eye and brain conditions. Eye care specialists conduct visual field examinations to discover blind spots (also known as scotomas) and other visual field defects, which may be an early indicator of the conditions mentioned above.
The dimensions and contours of a scotoma provide essential information regarding the presence and severity of disorders affecting the eye, optic nerve, and visual systems in the brain. For example, the damage to the optic nerve induced by glaucoma results in an exact deficiency in the visual field. Other illnesses, such as retina diseases, optic neuropathy, brain tumors, and stroke, are also linked to blind spots and other visual field impairments.
To get more insights about this report Download Free Sample Report
The evaluation of a patient's visual field sensitivity can be performed using computerized automated perimetry, a standardized and efficient procedure. For example, the Swedish Interactive Threshold Algorithm (SITA) is a method incorporated into The Humphrey Field Analyzer (Carl Zeiss Meditec, Inc). Currently, the SITA Standard is the approach that is typically utilized as the usual threshold estimating method in most clinical settings. Advanced Vision Analyser is a new portable, lightweight virtual reality headset equipped with optics that provide visual field analysis under test circumstances compatible with standard automated perimetry with eye-tracking and a cloud-based storage system that permits data backup also available for testing. An Elisar Standard Algorithm has been modified so that it can be used by the AVA (ESA). In addition, head-mounted perimetry devices have been stated to have the benefit of being particularly helpful in the case of patients who have physical limitations. Based on the comments made above, it can be deduced that market growth is anticipated during the forecast period.
Many public and private organizations are conducting awareness and advertising campaigns and workshops to raise awareness about eye health and vision care among the general public, optometrists, and ophthalmologists for diagnosing and treating ophthalmic diseases. These organizations are taking these steps to diagnose and treat ophthalmic diseases. In addition, several manufacturers provide ophthalmologists and technicians the opportunity to receive practical instruction in visual field analyzers by enrolling in one of the many available courses, tutorials, or workshops. These types of efforts help increase awareness about ocular diseases and diagnostic tools that are easily accessible, such as ophthalmic perimeters, which will boost the market.
There is a shortage of ophthalmologists, the cost of an automated visual field analyzer is very high, and there is increased competition and pricing pressure among the major suppliers. These are some of the issues predicted to impede the market's growth over the next few years.
Due to the sheer increase in the number of patients who suffer from ocular disorders and the rising demand for ophthalmic care, ophthalmologists and optometrists now have the potential to provide specialized services to their respective patient populations. Additionally, greater access to advanced ophthalmology technology in ophthalmic clinics in various underdeveloped nations, growing awareness regarding eye-related ailments, and the commitment of non-profit organizations towards the advancement of ophthalmic care are predicted to add to the market growth for automated visual field analyzers. These factors are expected to contribute to expanding the automated visual field analyzers market share
In 2020, the revenue share that came from North America was the greatest. Some reasons likely to increase the market in the forecast period are the rising prevalence of ophthalmic illnesses, the high adoption of the latest technologies, favorable reimbursement policies, and product releases by industry competitors. For instance, the American Association for Pediatric Ophthalmology and Strabismus emphasizes that cataracts remain the primary cause of blindness and vision loss globally. Visual impairment impairs a person's ability to do everyday duties, maintain employment, and care for dependents, all of which have a detrimental impact on the quality of life of the affected individual. Vision impairment can significantly increase the chance of injuries and fractures sustained from falling, resulting in the need for hospitalization in twenty percent of instances. These unfavorable effects will manifest differently in different patients according to the degree to which the cataract has developed. Approximately three children out of every 10,000 are diagnosed with cataracts. In addition, over the next 25 years, it is anticipated that the demand for cataract surgery in the province of Ontario, Canada, will increase by anywhere from 72% to 144%, while the operational capacity of publicly financed outpatient facilities will expand much more slowly. Consequently, there will be a rise in the requirement for automated visual field analyzers.
Further, based on product type, the market is bifurcated into Kinetic and Static. In 2020, the static market category held the most significant market share. For gauging the condition of the visual field, diagnosing glaucoma, and keeping track of changes brought on by the disease, the static perimeter is the technique of choice. One at a time, static perimetry evaluates various points on the field. Automated equipment is typically used for threshold static perimetry. It is used to screen for and monitor disorders that cause deficits such as scotomas, peripheral vision loss, and subtler vision loss. The screening, diagnosis, and follow-up of several eyes, retinal, optic nerve, and brain problems depend on perimetry testing. As a result of the previous remarks, the market is anticipated to hold the most significant market share during the forecast period.
The market is broken down into Glaucoma, Age-related macular degeneration (AMD), Scotoma, and Others based on application. In 2020, the glaucoma sector held a significant market share. Glaucoma is a collection of conditions that affect the eye's optic nerve and cause vision loss and blindness, according to the Centres for Disease Control and Prevention 2020. The natural fluid pressure inside the eyes gradually rises, which leads to glaucoma. However, a recent study found that glaucoma manifests with normal eye pressure. Because it is a chronic condition that progresses slowly over time without the sufferer noticing vision loss until the sickness is advanced, it is characterized as a "sneak thief of sight."
The market is broken down into Hospitals, Ophthalmic Clinics, and Others. The hospital market's expansion is driven by the increasing prevalence of eye-related diseases and technological advancements in the automated visual field analyzer. The demand for new installations may increase in the upcoming years due to the growing acquisitions between hospitals and ophthalmic non-profit organizations. Favorable reimbursement practices in industrialized nations and bettering healthcare infrastructure are, nonetheless, driving forces behind category expansion.
To get more findings about this report Download Market Share
| Report Metric | Details |
|---|---|
| Market Size in 2024 | USD 208.66 Million |
| Market Size in 2025 | USD 221.43 Million |
| Market Size in 2033 | USD 356.13 Million |
| CAGR | 6.12% (2025-2033) |
| Base Year for Estimation | 2024 |
| Historical Data | 2021-2023 |
| Forecast Period | 2025-2033 |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |
| Segments Covered | By Product Type, By Application, By End-user, By Region. |
| Geographies Covered | North America, Europe, APAC, Middle East and Africa, LATAM, |
| Countries Covered | U.S., Canada, U.K., Germany, France, Spain, Italy, Russia, Nordic, Benelux, China, Korea, Japan, India, Australia, Taiwan, South East Asia, UAE, Turkey, Saudi Arabia, South Africa, Egypt, Nigeria, Brazil, Mexico, Argentina, Chile, Colombia, |
Explore more data points, trends and opportunities Download Free Sample Report
Jay Mehta is a Research Analyst with over 4 years of experience in the Medical Devices industry. His expertise spans market sizing, technology assessment, and competitive analysis. Jay’s research supports manufacturers, investors, and healthcare providers in understanding device innovations, regulatory landscapes, and emerging market opportunities worldwide.
Speak To AnalystAvailable for purchase with detailed segment data, forecasts, and regional insights.
Get This Report